Pharmaceutical companies by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- SEK 51.44T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | SEK 101.4B | SEK 670.74 | 5.25% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | SEK 84.1B | SEK 1,212.67 | 2.33% up | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | SEK 48B | SEK 852.76 | 3.53% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | SEK 84.1B | SEK 1,287.93 | 1.65% up | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | SEK 87.2B | SEK 3,119.11 | 0.61% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | SEK 72.5B | SEK 520.79 | 0.78% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | SEK 46.8B | SEK 280.90 | 2.52% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | SEK 60.7B | SEK 3,036.24 | 1.68% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | SEK 98B | SEK 1,031.62 | 8.21% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | SEK 79.8B | SEK 475.16 | 2.87% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | SEK 46.1B | SEK 421.20 | 1.42% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | SEK 153.8B | SEK 789.50 | 1.15% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | SEK 48.6B | SEK 138.37 | 1.98% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | SEK 49.1B | SEK 282.37 | 0.23% down | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | SEK 61.1B | SEK 936.50 | 0.22% up | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | SEK 48.8B | SEK 508.75 | 2.04% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | SEK 65.9B | SEK 971.41 | 0.76% down | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | SEK 51B | SEK 609.92 | 0.57% down | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | SEK 93.5B | SEK 4,024.57 | 6.16% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | SEK 160.7B | SEK 2,502.99 | 2.32% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | SEK 75.4B | SEK 689.24 | 3.21% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | SEK 62B | SEK 438.78 | 0.43% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | SEK 53.4B | SEK 1,265.32 | 0.90% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | SEK 121.2B | SEK 625.52 | 5.20% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | SEK 40.5B | SEK 295.94 | 0.88% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | SEK 136B | SEK 272.16 | 3.60% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | SEK 266.8B | SEK 1,216.28 | 1.79% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | SEK 284.9B | SEK 393.20 | 0.05% down | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | SEK 71.4B | SEK 1,357.34 | 1.76% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | SEK 32.2B | SEK 166.26 | 1.55% up | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | SEK 75.7B | SEK 963.53 | 0.32% down | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | SEK 85.3B | SEK 106.66 | 1.64% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | SEK 74.5B | SEK 850.47 | 1.93% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | SEK 180.1B | SEK 2,744.87 | 0.41% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | SEK 250.5B | SEK 5,882.63 | 0.90% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | SEK 353.5B | SEK 870.04 | 2.55% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | SEK 203.4B | SEK 1,518.27 | 4.54% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | SEK 64.9B | SEK 1,597.95 | 0.31% down | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | SEK 77.3B | SEK 221.85 | 3.36% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | SEK 237B | SEK 206.71 | 0.54% down | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | SEK 126.9B | SEK 152.24 | 1.28% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | SEK 500.3B | SEK 428.77 | 1.01% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | SEK 1.62T | SEK 284.86 | 1.55% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | SEK 1.24T | SEK 605.78 | 2.84% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | SEK 401.1B | SEK 697.57 | 0.06% down | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | SEK 994.1B | SEK 9,610.14 | 1.27% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | SEK 1.39T | SEK 5,465.35 | 0.67% up | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | SEK 320.2B | SEK 519.32 | 1.66% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | SEK 468B | SEK 4,097.23 | 2.44% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | SEK 1.84T | SEK 1,063.84 | 0.03% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | SEK 3.45T | SEK 1,399.72 | 3.93% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | SEK 5.13T | SEK 2,904.98 | 2.38% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | SEK 58.5B | SEK 86.03 | 1.91% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | SEK 1.77T | SEK 401.18 | 3.01% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | SEK 12.53T | SEK 14,063.78 | 2.24% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | SEK 990.8B | SEK 494.32 | 1.22% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | SEK 6.68T | SEK 2,775.66 | 2.00% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | SEK 1.15T | SEK 479.23 | 0.79% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | SEK 2.98T | SEK 1,578.59 | 2.39% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | SEK 2.82T | SEK 1,817.11 | 1.90% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | SEK 689.8B | SEK 215.91 | 1.83% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1628 SEK).
Questions and answers
Which pharmaceutical companies rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceutical companies are in this ranking?
61 are ranked by short interest.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by short interest have a combined market value of SEK 51.44T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.